首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Advanced drug delivery reviews

缩写:ADV DRUG DELIVER REV

ISSN:0169-409X

e-ISSN:1872-8294

IF/分区:21.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引3288条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Mario de Lucio,Vivek Sree,Galen Shi et al. Mario de Lucio et al.
Subcutaneous (SC) injection has become the preferred route for self-administered monoclonal antibodies (mAbs), yet achieving consistent bioavailability remains challenging because molecular-scale interactions (protein self-association) prop...
Xiaoqing Fan,Chengcong Chen,Lin Zhang et al. Xiaoqing Fan et al.
Monoclonal antibody (mAb)-based therapies have revolutionized modern medicine, offering highly specific and effective treatments for a wide range of diseases, including cancer, autoimmune disorders, infectious diseases, and neurological con...
M Olazábal-Morán,C Blázquez-Barbadillo,E Pérez-Izquierdo et al. M Olazábal-Morán et al.
Reactive oxygen species (ROS) play a pivotal role in maintaining cellular balance, functioning both as essential messengers in signaling pathways and as agents of oxidative damage. In cancer their influence is paradoxical: moderate ROS leve...
Alexander S Evtushenko,Beatriz Lozano Torres,Ljiljana Fruk Alexander S Evtushenko
Despite a steady decline in overall cancer mortality, the survival rates of certain hard-to-treat cancers of the lung, liver, oesophagus, pancreas, and brain remain strikingly low. A key unmet need in this field is the development of effect...
Patrizia Tornabene,Estelle Berreur,Adrian Roth et al. Patrizia Tornabene et al.
While adeno-associated viral (AAV) vectors are the leading platform in gene therapy - with eight regulatory-approved products spanning multiple disease areas - their clinical performance remains only partially predictable. A major challenge...
Dariya Baizhigitova,I-En Wu,Lateefat Kalejaye et al. Dariya Baizhigitova et al.
High-concentration monoclonal antibody formulations are essential for subcutaneous delivery but often exhibit elevated viscosity, posing challenges in drug development, manufacturing, and administration. Understanding high concentration vis...
Dengxuan Mao,Bingqian Li,Jing Li et al. Dengxuan Mao et al.
Nanodrug delivery systems (NDDSs) offer distinctive advantages in tumor immunotherapy, not only by enhancing drug distribution, targeting, and bioavailability but also by actively engaging in immune regulation through multiple mechanisms. I...
Kimia Asadi Jozani,Karen Shen,Nicky Anvarihamedani et al. Kimia Asadi Jozani et al.
Nanoparticles have become an essential platform for next-generation drug delivery and therapeutic development, yet clinical translation remains limited by an incomplete understanding of their interactions within human biological systems. Or...
Wei Wang,Yuxin Fang,Chunquan Sheng Wei Wang
While proteolysis-targeting chimeras (PROTACs) represent a breakthrough in targeted protein degradation (TPD), their applicability is restricted by fundamental limitations. Mechanistically, they are mainly limited to proteins with accessibl...
Paula K N Alves,Ian C Sutton,James D Byrne et al. Paula K N Alves et al.
Gasotransmitters, including nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H₂S), are small endogenously produced signaling molecules that regulate critical intra- and intercellular processes. These gases modulate ion channe...